术前MDCT环形强化与胰周脂肪条索影预测PDAC隐匿性转移
该回顾性研究纳入502例影像学诊断为可切除或交界可切除的PDAC患者,探索术前MDCT征象及临床生物标志物对隐匿性转移的预测价值。多因素分析显示肿瘤大小、可切除性、环形强化、胰周脂肪条索影及CA125水平为独立预测因子,联合模型AUC达0.823。
要点
- 环形强化和胰周脂肪条索影在隐匿性转移组更常见,是独立预测因子。
- 联合影像征象与临床特征(肿瘤大小、可切除性、CA125)的模型AUC最高达0.823。
- 术前MDCT发现环形强化或胰周脂肪条索影时,应警惕隐匿性转移可能。
核心结论
- 环形强化、胰周脂肪条索影、肿瘤大小、肿瘤可切除性及CA125水平是PDAC隐匿性转移的风险因素。
- 联合影像与临床特征的模型有助于术前预测PDAC的隐匿性转移,最高AUC为0.823。
研究设计与样本
- 回顾性研究,纳入2018年1月至2021年12月影像学诊断为可切除或交界可切除并接受手术探查的PDAC患者502例。
- 中位年龄64岁(四分位距57-70岁),男性294例;根据探查是否发现远处转移分为隐匿性转移组和非隐匿性转移组。
- 采用单因素和多因素logistic回归分析确定影像学和临床预测因素,通过区分度和校准度评估模型性能。
关键影像表现/征象
- 环形强化和胰周脂肪条索影在隐匿性转移组比非隐匿性转移组更常见。
- 502例中68例(13.5%)发现远处转移,其中45例仅肝转移、19例仅腹膜转移、4例同时有肝和腹膜转移。
诊断标准与关键数值
- 多因素分析中肿瘤大小(p=0.028)、肿瘤可切除性(p=0.031)、环形强化(p<0.001)、胰周脂肪条索影(p<0.001)和CA125水平(p=0.021)为隐匿性转移的独立预测因子。
- 上述各特征的AUC分别为:肿瘤大小0.703、肿瘤可切除性0.594、环形强化0.638、胰周脂肪条索影0.655、CA125水平0.631。
- 联合模型显示最高AUC为0.823。
临床应用与阅片要点
- 术前MDCT阅片时需关注环形强化和胰周脂肪条索影,结合肿瘤大小、可切除性及CA125水平综合评估隐匿性转移风险。
- 对影像学诊断为可切除或交界可切除的PDAC患者,若存在上述风险因素,应提示临床进一步排查远处转移。
局限性
- 回顾性研究设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVE: To identify the radiological features and clinical biomarkers that could predict the occult metastasis (OM) of pancreatic ductal adenocarcinoma (PDAC).
MATERIALS AND METHODS: This retrospective study included PDAC patients who were radiologically diagnosed resectable (R) or borderline resectable (BR) and underwent surgical exploration from January 2018 to December 2021. Depending on whether distant metastases were found during the exploration, patients were divided into OM and non-OM groups. Univariate and multivariable logistic regression analyses were performed to determine the radiological and clinical predictive factors for occult metastasis. Model performance was determined by discrimination and calibration.
RESULTS: A total of 502 patients (median age, 64 years; interquartile range, 57-70 years; 294 men) were enrolled, among which 68 (13.5%) patients were found with distant metastases, with 45 liver-only, 19 peritoneal-only, four patients had both liver and peritoneal metastases. Rim enhancement and peripancreatic fat stranding were more frequent in the OM group than in the non-OM group. Tumor size (p = 0.028), tumor resectability (p = 0.031), rim enhancement (p < 0.001), peripancreatic fat stranding (p < 0.001) and level of CA125 (p = 0.021) were independent predictors of occult metastasis according to the multivariable analyses, and the areas under the curve (AUCs) of these characteristics were 0.703, 0.594, 0.638, 0.655, 0.631, respectively. The combined model showed the highest AUC of 0.823.
CONCLUSIONS: Rim enhancement, peripancreatic fat stranding, tumor size, tumor resectability and level of CA125 are risk factors for OM of PDAC. The combined model of radiological and clinical features may help the preoperative prediction of OM in PDAC.
引用
- Bai, Wu, Dai, et al. Rim Enhancement and Peripancreatic Fat Stranding in Preoperative MDCT as Predictors for Occult Metastasis in PDAC Patients. Acad Radiol. 2023. PMID: 37024338. doi:10.1016/j.acra.2023.03.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。